{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:35:06Z","timestamp":1786980906891,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T00:00:00Z","timestamp":1257811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10552-009-9461-5","type":"journal-article","created":{"date-parts":[[2009,11,9]],"date-time":"2009-11-09T01:50:23Z","timestamp":1257731423000},"page":"289-300","source":"Crossref","is-referenced-by-count":65,"title":["Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study"],"prefix":"10.1007","volume":"21","author":[{"given":"Ilir","family":"Agalliu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika M.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Koopmeiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Ostrander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,10]]},"reference":[{"key":"9461_CR1","volume-title":"Cancer facts and figures: 2009","author":"American Cancer Society","year":"2009","unstructured":"American Cancer Society (2009) Cancer facts and figures: 2009. American Cancer Society, Atlanta"},{"issue":"2","key":"9461_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al (2000) Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78\u201385","journal-title":"N Engl J Med"},{"issue":"1","key":"9461_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9","volume":"89","author":"DG Bostwick","year":"2000","unstructured":"Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM et al (2000) Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89(1):123\u2013134","journal-title":"Cancer"},{"issue":"1","key":"9461_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2004.09.028","volume":"41","author":"SK Pathak","year":"2005","unstructured":"Pathak SK, Sharma RA, Steward WP, Mellon JK, Griffiths TR, Gescher AJ (2005) Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. Eur J Cancer 41(1):61\u201370","journal-title":"Eur J Cancer"},{"issue":"2","key":"9461_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L, Kumar B, Koul S, Maroni P, Koul HK (2009) Oxidative stress in prostate cancer. Cancer Lett 282(2):125\u2013136","journal-title":"Cancer Lett"},{"issue":"10","key":"9461_CR6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","volume":"17","author":"MS Cooke","year":"2003","unstructured":"Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. Faseb J 17(10):1195\u20131214","journal-title":"Faseb J"},{"issue":"24","key":"9461_CR7","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.2174\/0929867033456341","volume":"10","author":"SC Sikka","year":"2003","unstructured":"Sikka SC (2003) Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention\u2014a mechanistic approach. Curr Med Chem 10(24):2679\u20132692","journal-title":"Curr Med Chem"},{"issue":"24","key":"9461_CR8","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1158\/0008-5472.CAN-04-2323","volume":"64","author":"BA Rybicki","year":"2004","unstructured":"Rybicki BA, Rundle A, Savera AT, Sankey SS, Tang D (2004) Polycyclic aromatic hydrocarbon-DNA adducts in prostate cancer. Cancer Res 64(24):8854\u20138859","journal-title":"Cancer Res"},{"issue":"2","key":"9461_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2005.07.029","volume":"239","author":"BA Rybicki","year":"2006","unstructured":"Rybicki BA, Nock NL, Savera AT, Tang D, Rundle A (2006) Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. Cancer Lett 239(2):157\u2013167","journal-title":"Cancer Lett"},{"issue":"4","key":"9461_CR10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1055-9965.EPI-06-0973","volume":"16","author":"D Tang","year":"2007","unstructured":"Tang D, Liu JJ, Rundle A, Neslund-Dudas C, Savera AT, Bock CH et al (2007) Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol Biomarkers Prev 16(4):803\u2013808","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1\u20132","key":"9461_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(03)00287-7","volume":"193","author":"M Christmann","year":"2003","unstructured":"Christmann M, Tomicic MT, Roos WP, Kaina B (2003) Mechanisms of human DNA repair: an update. Toxicology 193(1\u20132):3\u201334","journal-title":"Toxicology"},{"issue":"5507","key":"9461_CR12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1056154","volume":"291","author":"RD Wood","year":"2001","unstructured":"Wood RD, Mitchell M, Sgouros J, Lindahl T (2001) Human DNA repair genes. Science 291(5507):1284\u20131289","journal-title":"Science"},{"key":"9461_CR13","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0962-8924(01)02149-3","volume":"11","author":"AJ Pierce","year":"2001","unstructured":"Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M (2001) Double-strand breaks and tumorigenesis. Trends Cell Biol 11:S52\u2013S59","journal-title":"Trends Cell Biol"},{"key":"9461_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/carcin\/23.5.687","volume":"23","author":"SP Jackson","year":"2002","unstructured":"Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687\u2013696","journal-title":"Carcinogenesis"},{"issue":"1","key":"9461_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/taap.2002.9518","volume":"185","author":"JJ Hu","year":"2002","unstructured":"Hu JJ, Mohrenweiser HW, Bell DA, Leadon SA, Miller MS (2002) Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharmacol 185(1):64\u201373","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"9461_CR16","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12):1513\u20131530","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9461_CR17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/0008-5472.CAN-03-2670","volume":"64","author":"JJ Hu","year":"2004","unstructured":"Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, Lohman K et al (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 64(3):1197\u20131201","journal-title":"Cancer Res"},{"issue":"10","key":"9461_CR18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/aje\/kwi318","volume":"162","author":"RJ Hung","year":"2005","unstructured":"Hung RJ, Hall J, Brennan P, Boffetta P (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162(10):925\u2013942","journal-title":"Am J Epidemiol"},{"issue":"8","key":"9461_CR19","first-page":"2253","volume":"62","author":"J Xu","year":"2002","unstructured":"Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA et al (2002) Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 62(8):2253\u20132257","journal-title":"Cancer Res"},{"issue":"11","key":"9461_CR20","first-page":"1279","volume":"11","author":"CH Gils van","year":"2002","unstructured":"van Gils CH, Bostick RM, Stern MC, Taylor JA (2002) Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev 11(11):1279\u20131284","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"9461_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1055-9965.EPI-03-0053","volume":"13","author":"BA Rybicki","year":"2004","unstructured":"Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS (2004) DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13(1):23\u201329","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"9461_CR22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1055-9965.EPI-04-0809","volume":"14","author":"JD Ritchey","year":"2005","unstructured":"Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P et al (2005) Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev 14(7):1703\u20131709","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"9461_CR23","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/carcin\/bgl022","volume":"27","author":"NL Nock","year":"2006","unstructured":"Nock NL, Cicek MS, Li L, Liu X, Rybicki BA, Moreira A et al (2006) Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis 27(9):1842\u20131848","journal-title":"Carcinogenesis"},{"issue":"1","key":"9461_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0022-5347(05)00042-X","volume":"175","author":"L Chen","year":"2006","unstructured":"Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY (2006) Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 175(1):108\u2013112 (discussion 12)","journal-title":"J Urol"},{"issue":"2","key":"9461_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejca.2006.11.005","volume":"43","author":"H Hirata","year":"2007","unstructured":"Hirata H, Hinoda Y, Tanaka Y, Okayama N, Suehiro Y, Kawamoto K et al (2007) Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer 43(2):231\u2013237","journal-title":"Eur J Cancer"},{"issue":"4","key":"9461_CR26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.pcan.4501027","volume":"11","author":"S Hooker","year":"2008","unstructured":"Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA (2008) NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis 11(4):349\u2013356","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"10","key":"9461_CR27","first-page":"881","volume":"8","author":"JL Stanford","year":"1999","unstructured":"Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK (1999) Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8(10):881\u2013886","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9461_CR28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/aje\/kwn141","volume":"168","author":"I Agalliu","year":"2008","unstructured":"Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL (2008) Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168(3):250\u2013260","journal-title":"Am J Epidemiol"},{"issue":"6","key":"9461_CR29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/10.6.591","volume":"10","author":"S Sunyaev","year":"2001","unstructured":"Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P (2001) Prediction of deleterious human alleles. Hum Mol Genet 10(6):591\u2013597","journal-title":"Hum Mol Genet"},{"key":"9461_CR30","first-page":"9.16","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Isolation of high-molecular weight DNA from mammalian cells. In: Nolan C (ed) Molecular cloning: a laboratory manual. Cold Spring Harbor Press, Plainview, pp 9.16\u201399.9"},{"key":"9461_CR31","doi-asserted-by":"crossref","DOI":"10.56021\/9780801861406","volume-title":"Analysis of human genetic linkage","author":"J Ott","year":"1999","unstructured":"Ott J (1999) Analysis of human genetic linkage. John Hopkins University Press, Baltimore"},{"key":"9461_CR32","volume-title":"Statistical methods in cancer research, volume 1\u2014the analysis of case-control studies","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE (1980) Statistical methods in cancer research, volume 1\u2014the analysis of case-control studies. International Agency for Research on Cancer, Lyon"},{"key":"9461_CR33","volume-title":"Applied regression analysis and multivariate methods","author":"DG Klienbaum","year":"2007","unstructured":"Klienbaum DG, Nizam A, Kupper L, Muller KE (2007) Applied regression analysis and multivariate methods, 4th edn. Duxbury Press, Pacific Grove","edition":"4"},{"issue":"6","key":"9461_CR34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/oxfordjournals.aje.a114338","volume":"123","author":"N Dubin","year":"1986","unstructured":"Dubin N, Pasternack BS (1986) Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol 123(6):1101\u20131117","journal-title":"Am J Epidemiol"},{"issue":"15","key":"9461_CR35","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"The Breast Cancer Linkage C","year":"1999","unstructured":"The Breast Cancer Linkage C (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310\u20131316","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"9461_CR36","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0959-8049(99)00135-5","volume":"35","author":"O Johannsson","year":"1999","unstructured":"Johannsson O, Loman N, Moller T, Kristoffersson U, Borg A, Olsson H (1999) Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer 35(8):1248\u20131257","journal-title":"Eur J Cancer"},{"key":"9461_CR37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1023\/A:1011272919982","volume":"12","author":"H Eerola","year":"2001","unstructured":"Eerola H, Pukkala E, Pyrhonen S, Blomqvist C, Sankila R, Nevanlinna H (2001) Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland). Cancer Causes Control 12:739\u2013746","journal-title":"Cancer Causes Control"},{"issue":"7","key":"9461_CR38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jmg.39.7.457","volume":"39","author":"H Tulinius","year":"2002","unstructured":"Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V et al (2002) The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 39(7):457\u2013462","journal-title":"J Med Genet"},{"key":"9461_CR39","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdh474","volume":"15","author":"JL Bermejo","year":"2004","unstructured":"Bermejo JL, Hemminki K (2004) Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol 15:1834\u20131841","journal-title":"Ann Oncol"},{"key":"9461_CR40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","volume":"42","author":"CJ Asperen van","year":"2005","unstructured":"van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42:711\u2013719","journal-title":"J Med Genet"},{"key":"9461_CR41","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s001090050162","volume":"75","author":"S Sigurdsson","year":"1997","unstructured":"Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfj\u00f6rd JE et al (1997) BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 75:758\u2013761","journal-title":"J Mol Med"},{"issue":"20","key":"9461_CR42","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408","journal-title":"N Engl J Med"},{"key":"9461_CR43","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-03-0604","volume":"10","author":"T Kirchhoff","year":"2004","unstructured":"Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C et al (2004) BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 10:2918\u20132921","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9461_CR44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/1078-0432.CCR-08-1822","volume":"15","author":"I Agalliu","year":"2009","unstructured":"Agalliu I, Gern R, Leanza S, Burk RD (2009) Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res 15(3):1112\u20131120","journal-title":"Clin Cancer Res"},{"key":"9461_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/345310","volume":"72","author":"SM Edwards","year":"2003","unstructured":"Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P et al (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72:1\u201312","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9461_CR46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.bjc.6603929","volume":"97","author":"I Agalliu","year":"2007","unstructured":"Agalliu I, Karlins E, Kwon EM, Iwasaki LM, Diamond A, Ostrander EA et al (2007) Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. Br J Cancer 97(6):826\u2013831","journal-title":"Br J Cancer"},{"issue":"8","key":"9461_CR47","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1055-9965.EPI-08-0556","volume":"17","author":"EA Ostrander","year":"2008","unstructured":"Ostrander EA, Udler MS (2008) The role of the BRCA2 gene in susceptibility to prostate cancer revisited. Cancer Epidemiol Biomarkers Prev 17(8):1843\u20131848","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"9461_CR48","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/carcin\/19.7.1239","volume":"19","author":"E Braithwaite","year":"1998","unstructured":"Braithwaite E, Wu X, Wang Z (1998) Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 19(7):1239\u20131246","journal-title":"Carcinogenesis"},{"issue":"3","key":"9461_CR49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jcb.10700","volume":"91","author":"EA Platz","year":"2004","unstructured":"Platz EA, De Marzo AM, Giovannucci E (2004) Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem 91(3):553\u2013571","journal-title":"J Cell Biochem"},{"issue":"4 Pt 1","key":"9461_CR50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.ju.0000085675.96097.76","volume":"170","author":"FI Kondylis","year":"2003","unstructured":"Kondylis FI, Moriarty RP, Bostwick D, Schellhammer PF (2003) Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias. J Urol 170(4 Pt 1):1189\u20131193","journal-title":"J Urol"},{"issue":"17","key":"9461_CR51","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/dji248","volume":"97","author":"PC Albertsen","year":"2005","unstructured":"Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PDH (2005) Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97(17):1248\u20131252","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-009-9461-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9461-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T09:14:33Z","timestamp":1685178873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-009-9461-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,10]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["9461"],"URL":"https:\/\/doi.org\/10.1007\/s10552-009-9461-5","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,10]]}}}